Reflection and Connection: Surviving Residency and the Start of Personal and Professional Development Groups (Addison, 1/29/25)

See a recording of this session HERE

Many thanks to Dr. Ritch Addison, long time behavioral health faculty and foundation layer for our Personal and Professional Development (P&PD) Groups that still run every Thursday at Santa Rosa Family Medicine Residency. 

He spent his time with us on Wednesday morning reflecting on the experience of residency training: the constant pressure, the feeling of never enough time, too much to do with the time, dying patients, asking for help vs. not asking for help, learning the ropes and the conflict and contradiction of ideals/values and visions with every day practices. 




I cannot do his 40+ years of wisdom justice with a summary here (just watch the recording), but I do want to highlight and remind us of his model for Surviving Residency:

1) Covering over> the focus on mastering the procedures of medicine, which requires putting on blinders so that you can do what you have to do to get through your day/rotation/year/training.

2) Over reflecting>> too many reflections, filled with painful self-doubt, feelings of imposter syndrome, Did I make the right choice?

And, as Ritch stressed, neither state is stable. In fact, it's the jarring motion between the two modes that is what is so challenging in residency. "You need time to unload one experience and load the next, and you just don't have time". 



The answer? Ritch says, is connection. A place where you can do just this -- unload the conflictual and unconscious feelings, take a step outside those jarring moments>> P&PD. 

The Pelvic Exam through a Trauma Informed Lens (Goldberg-Boltz, 1/22/25)

A recording of the presentation is available HERE

Many thanks to Dr. Nicole Boltz for an excellent presentation this week on The Pelvic Exam through a Trauma-Informed Lens. This was both a practical and meaningful presentation -- one which will stick wit you as you move quickly through your clinic day.

Here are my notes:



  • We should all be doing universal sexual assault screening for ALL patients (do not leg bias guide you). There are many ways to do this screening that are patient-centered, but there is no one right way. Remember it may take many visits (or many years) for a patient to feel comfortable enough to disclose. Meet the patient where they are.

  • The four Rs of a trauma-informed approach (SAMHSA)
    • RealizeUnderstand the impact of trauma on people and communities
    • RecognizeIdentify the signs and symptoms of trauma
    • RespondIntegrate knowledge about trauma into policies, procedures, and practices
    • Resist re-traumatizationTake action to prevent re-traumatizing individuals
  • Find humor even in the hard things we do: https://www.instagram.com/reel/C7kbKUpsuAD/?igsh=NTc4MTIwNjQ2YQ%3D%3 (this is super funny!!!!!!)

Okay, onto the Pelvic Exam:
  • Prepare a safe and non-judgmental space
    • ideally meet the patient prior to the exam or procedure (when dressed!)
    • set the ground for empowerment: they are in charge, we go at their pace, they can stop whenever
    • explain the procedure and purpose
    • ask if they want to see/touch/listen to the instruments
    • ask of they want a support person in the room
    • ask if they want you to know anything before the exam
    • ask what can be done to make the exam more comfortable
    • ask for any questions
  • Language, language, language
    • the goal is to use non-triggering language
    • empower the patient with your language (they are in charge)
    • framing matters: "when/if you are able" and "you MIGHT feel" and "would you like me to proceed or shall I pause?" and "tell me when you're ready"
    • consider these substitutions: exam table (instead of bed), drape (rather than sheet), foot rests (rather than stirrups), instruments (rather than device names)
  • Body positions matter: for some, certain positions can be triggering. Ask which position is most comfortable for them
    • in/out footrests, frog legged, on exam table
    • never force legs open
    • ask permission to move/touch body, considering tapping knee to get legs to drop

    • During exam
    • Consider distractions: toe wiggling, tapping on knees in a pattern, tapping on chest, deep breathing
  • Getting dressed: After the exam, allow patient to get dressed before you discuss findings/assessment/plans. Then explain what you did, what you saw, what are the next steps.

Assessing Preferences for Patients who Lack Decision Making Capacity (Andereck & Fulbright 1/15/25)

 A recording of this presentation is available HERE.

Deep gratitude to Dr. William Andereck and Robert Fulbright for a thought-provoking presentation this week on Decision-making Capacity. This is an issue that we encounter with surprising frequency on the inpatient medicine service, and the distress that decision-making capacity causes on patients and providers is intense. 

This is definitely a presentation that is better watched than summarized, but I did take a few notes. 

The concept of Patient Consent first arose in 1914, Benjamin Cardoza, "Every human being with a sound mind has a right to determine what he does with his own body."

This concept, of course, was brought to light in the context of the Tuskegee Study (which ran 1932-1972) and the subsequent Belmont Report (published in 1979). It was the Belmont Report (which I don't think I have ever heard of before this lecture) in which Informed Consent became a thing. 

The Belmont Report outlined 3 principles:

  1. Beneficence
  2. Justice
  3. Respect for persons (which was ultimately morphed into Respect for the autonomy of the person)
Non-maleficence (do no harm) was not included.
Of note, Dr. Andereck stressed, autonomy at the time was not meant to be interpreted as "the right to demand whatever you want". Rather, it was meant as a freedom from interference, the right to say "no". Somewhere along the last 50 years, it has become interpreted as a "positive right". From Dr. Andereck's perspective, early bioethicists were clear that if a medical intervention does not benefit the people, there is no obligation. 

Competence is defined as 1) having values and goals 2) the ability to communicate those and 3) reasons to do or not do something related to this goals. Competence is NOT the same as Capacity. 

Capacity is specific>> the question should always be capacity for what?
Capacity it temporal>> it can wax and wane
Capacity is the perspective of a 3rd party>> patients never tell us that they are incapacitated. It must be observed from an outside party.

Applied to medicine, then, capacity becomes
  1. the ability to 



Long COVID (Siqueiros, 1/8/25)

A recording of this presentation is available HERE.

***

This week's Grand Rounds on Long COVID was a practice-changing presentation! If you are caring for patients in a primary care setting or know someone who is suffering from Long COVID, I highly recommend you watch the entire presentation by Dr. Marcos Siqueiros, of KP Santa Clara. Dr. Siqueiros covered a TON of material, including what is known about Long COVID's epidemiology, risk factors, pathophysiology, and both medication and lifestyle/behavioral recommendations for management of Long COVID. 

Here are my notes:

Unfortunately, there are a number of different definitions of Long COVID

  • CDC: symptoms persist >4 weeks after COVID (live virus no longer detectable)
  • WHO: symptoms present >3 months after acute COVID illness, lasting at least 2 months
  • National Academies of Science: infection-associated chronic conditions after SARS-COV2 infection, present for at least 3 months as either continuous, relapsing/remitting or progressive, affecting one or more organ systems.
  • PASC: Post-Acute Sequalae of COVID, lasting 4 weeks or longer


Epidemiology
17-18% of all US adults reported having long COVID at some point since 2020, ~7% having ongoing symptoms
20 million adults in US, 2 million adults in CA are experiencing Long COVID today
Long COVID numbers have declined, but rate has been consistent 6-7%

Characteristics of  those who develop Long COVID
-higher rates of comorbid/preexisting health conditions, tend to have experienced more severe COVID illness or were hospitalized
-unvaccinated, greater # of infections PRIOR to vaccination increases risk of Long COVID
-adult population slightly lower (3x rate for people in 50s compared to 80s)
-higher rates in Females, Latinx/Hispanic
-increased rates in white Americans, rural regions, lower income households
-bisexual/transgender more likely to report Long COVID sx

Economic costs of Long COVID
-2-4 million people in US out of work due to disability to due Long COVID
-$168 billion/year, revised to $3.7 trillion/year

Clinical Manifestations
Long COVID symptoms can lingers weeks, months, longer. Severity and type can vary. Most patients will experience resolution of their symptoms by 1 year. Patience is key.
>200 symptoms under the Long-COVID umbrella, extremely non-specific, hard to categorize broadly
Symptoms tend to wax and wane, can be linked to any severity of acute infection (most people now only get mild COVID)
Symptoms vary according to variant

Pathophysiology
A complete understanding of pathophysiology is not established, but basic science is working to understand mechanism/pathways that can explain symptoms. 
-Direct AND indirect mechanisms
-ACE2 receptors ubiquitous and expressed in various tissues in the body (heart, lungs, GI), involved in breaking down Angiotensin 2 to promote homeostasis, also downregulates inflammation. If left unchecked/unregulated, can get uncontrolled/chronic inflammation. When COVID infects the host, binds to ACE2 receptor sites, which makes it less available to break down Angiotensin 2>> release of cytokines and inflammatory mediators>> immune dysregulation and chronic inflammation

Clinical management 3 common conditions:

1) Chronic Fatigue is the MOST common symptom reported with Long COVID, can last weeks/months/years. Lingers the longest. This is profound and unusual persistent sense of exhaustion after simplest of activities, including ADLs. By definition, Chronic Fatigue must be present >6 months, otherwise it is called Long-COVID with prolonged post-viral fatigue. 

Post-Exertional Malaise (PEM) commonly expressed by people with Long COVID. Can be induced by either physical or cognitive activities. Sudden drop of energy and profound fatigue that leads to struggle to complete activities for the day. Can be hours to days. Creates frustration, discouragement and fear. 

A small observational 2023 study from Amsterdam found that abnormalities due to PEM are due to significant defects in skeletal muscle due to exercise-induced myopathy with infiltration of immune t cells and amyloid deposits. Also severe reduction of mitochondrial enzyme activity>> premature lactic acid buildup in skeletal muscles. This explains marked reduction in exercise capacity. 

Treatment/Management for Long-COVID associated Chronic Fatigue
Medication
Low dose naltrexone (LDN), non selective opioid antagonist, seems to help with chronic fatigue. Well tolerated, reduced CNS inflammation, upregulates endorphins.
Dosed at bedtime 0.5mg-4.5mg (start low go slow, increase q2-3 weeks)
Side effects: vivid dreams, insomnia, GI upset (mild). If sleep disturbances, can give earlier in day
Anecdotally, about 1/2 of people that try LDN report some improvement in fatigue and brain fog

Lifestyle 
Stress relief, sleep, nutrition 
People able to reduce sugar and caffeine intake demonstrate less fatigue
Avoiding dehydration is key
Review meds and others substances that can worsen fatigue
Control comorbid chronic conditions that also exacerbate fatigue (DM, OSA)
Pacing is a mindset of learning to conserve energy balancing time spent on activity vs. time spent on rest with goal to increase participation in activities. Deliberate self-management strategy. Has evidence in Long COVID to improve energy and endurance



2) Brain fog is an umbrella term used to describe cognitive dysfunction associated with Long COVID. It is vague. No way to distinguish. Areas of cognition impacted: memory (working memory), attention (conversation details, following complex stories, multi-tasking), fluency (word finding), executive function (step by step actions, organizing or performing cognitive tasks). 

Possible mechanisms of brain fog: 
Direct: COVID enters CNS by retrograde transport along olfactory nerves, virus can cause direct toxic injury
Indirect: disrupted blood brain barrier, more permeable and porous. Disruption of BBB allows entry of inflammatory mediators to enter the CNS, disrupting cognitive function (2023 study in Nature Neuroscience found elevated biomarkers in people with long COVID and brain fog similar to TBI patients). Further study needed.

Off label Medications
  • Guanfacine (old drug used for hypertension, selective alpha 2 receptor agonist, thought to improve working memory, improved attention. Used in TBI, ADD). Can drop BP. Protocol out of Yale combine guanfacine with NAC. (see below)
  • Also SSRI/SNRI, stimulants (care w/habituation, tolerance, should be used rarely), amantadine (influenza anti-viral) increases dopamine release and prevents reuptake (used in TBI and CFS, 100mg BID)
  • LDN (see above)

Lifestyle 
Stress reduction, screening for and management of anxiety/depression
Reduce neuroinflammation with healthier eating (low in carbs, simple sugar, low in caffeine)
Avoid neurotoxic substances: ETOH, cannabis, other drugs
Limit screen time (neuro-stressor), too much screen time can overtax brain and worsen brain fog
Quantity/quality of sleep: sleep hygiene rests nervous system, reduces neuroinflammation (turn off electronic devices)


3) Orthostatic Intolerance (OI) and Postural orthostatic tachycardia syndrome (POTS)

OI: uncomfortable symptoms that arise when moving to an upright position (faint, dizzy, palpitations, chest pain, SOB, blurry vision, coat-hanger headache). Often patients with OI need to lay down or sit to make symptoms to stop.

POTS: Same symptoms of OI, accompanied by HR increases >30 bpm within 10 minutes of standing

OI and POTS are both due to dysregulation of Sympathetic and Parasympathetic balance, probably involves Vagus nerve. Need to r/o underlying cardiac conditions! 

NASA lean test can distinguish OI vs. POTS
Three pillars of management of OI/POTS:
  1. Hydration: ultra hydration, drink at least 2L of fluid/day, wake up and hydrate first thing int he AM, hydrate every 2-3 hours
  2. Salt Loading: increase sodium intake to at least 3000mg/day, can go as high as 10,000mg/day (very high), add salt or sodium tablets
  3. Compression: compression garments in lower limbs, torso
                    mid-thigh/waste-high compression stocking (20-30mmHg compression)
                    belly/abdominal binders
                   commercial body shapewear (e.g. Spanx)

Also, discourage people from laying around in bed for prolonged time, can worsen symptoms in the long run. If rest needed, avoid resting flat (HOB up by 6-10 inches) to minimize orthostasis. Get up slowly, give CNS chance to accommodate posture

Avoid anything that worsens dehydration: alcohol, caffeine, hot temperature (stream baths, hot day)

Medications (see image below)
Non-selective BB, e.g. propranolol
Flourinef (BP)
Midodrine
Ivabradine
IV saline boluses

Additional Notes:
-Paxlovid not shown to treat or prevent Long COVID
-Vaccines do prevent Long COVID, if shots tolerated, they are probably beneficial (large multi-national studies). The more boosters you get prior to getting COVID, less likely you are to get Long-COVID. For some people, vaccination improved Long COVID symptoms. However, vaccination (and reinfection) can also aggravate long COVID symptoms. Shared decision-making needed. Reasonable to pursue vaccination even in setting of long COVID. 

Be holistic, flexible, tailor to patient's individual needs.
Multidisciplinary approach is key, including PT/OT/SLT, nutrition, health education, mental health services
Advocate for patients. Validation and support are important. Bring patients in office for in person exam (no later than 3 months after symptoms started, rule out other chronic conditions)
There are no biomarkers to identify Long COVID, it's a clinical diagnosis
Look for red flag conditions (e.g. heart disease, metabolic/endocrine, etc) and optimize underlying chronic conditions.
Patience is key.




Advancements in GLP-1 Receptor Agonists: Where we are and where we're going (Felton, 2/19/25)

 A recording of the presentation is available HERE . *** Many thanks to Dr. Erin Felton for an excellent presentation on a hot topic: GLP-1 ...